What TV doesn't, print can't; we deliver.
What TV doesn't, print can't; we deliver.
Bharat Biotech’s Intranasal Vaccine receives both Primary series and Heterologous booster approval from from the Central Drugs Standard Control Organisation (CDSCO). This is first ever Intranasal Vaccine approved under restricted emergency use for 18+ for heterologous booster doses.. This vaccine was tested on 3100 candidates at 14 trial sites across India majorly for immunogenicity during […]
